Back to results
US 2022/0009938 A1Published application
11,13-modified saxitoxins for the treatment of pain
AssigneeSiteone Therapeutics, Inc.
InventorsHassan PAJOUHESH, Xiang ZHOU, John MULCAHY
Life of this patent
Estimating the term…
Abstract
Provided herein are compounds, pharmaceutical compositions comprising the compounds, methods of preparing the compounds, and methods of using the compounds and compositions in treating conditions associated with voltage-gated sodium channel function where the compounds are 11,13-modified saxitoxins according to Formula (I): (Formula (I)); where R1, and R2 are as described herein.
Claims71
A compound of Formula (I):
- wherein
- R1 is —NR3aR3, —NR4C(O)R4a, heteroaryl, —CH2NH2, —CH2CH2NH2, —CH2NH3+, —CH2CH2NH3+, —NR5S(O)2R5a, —NR6C(O)NR6aR6b, or —NR8C(O)OR8a;
- R2 is —NR7C(O)R7a;
- R3 is hydrogen or C1-6alkyl;
- R3a is hydrogen or C1-6alkyl;
- R4 is hydrogen or C1-6alkyl;
- R4a is hydrogen;
- C1-6alkyl;
- halo-C1-6alkyl;
- amino-C1-6alkyl;
- C1-6alkylaminoC1-6alkyl;
- di-C1-6alkylaminoC1-6alkyl;
- C1-6alkoxyC1-6alkyl;
- cycloalkyl;
- cycloalkylalkyl;
- aryl optionally substituted with 1, 2, 3, or 4 R4b groups;
- aralkyl where the aryl portion is optionally substituted with 1, 2, 3, or 4 R4b groups;
- heterocycloalkyl optionally substituted with 1, 2, 3, or 4 R4b groups;
- heteroaryl optionally substituted with 1, 2, 3, or 4 R4b groups;
- heteroaralkyl where the heteroaryl portion is optionally substituted with 1, 2, 3, or 4 R4b groups;
- heterocyclic optionally substituted with 1, 2, 3, or 4 R4b groups;
- or heterocyclicalkyl optionally substituted with 1, 2, 3, or 4 R4b groups;
- each R4b, when present, is independently C1-6alkyl, hydroxy, halo, halo-C1-6alkyl, hydroxy-C1-6alkyl, C1-6alkoxy, cyano, phenyl, or —O—(C1-6alkylene)-OZ, wherein Z is hydrogen or
- wherein Y is hydrogen or Boc group, and represents the point of attachment;
- R5 is hydrogen or C1-6alkyl;
- R5a is heterocycloalkyl, amino, C1-6alkylamino, or di-C1-6alkylamino;
- R6 is hydrogen or C1-6alkyl;
- R6a is hydrogen, or C1-6alkyl;
- R6b is hydrogen, C1-6alkyl, C1-6alkoxy or cycloalkyl;
- R8 is hydrogen or C1-6alkyl;
- R5a is hydrogen, C1-6alkyl, cycloalkyl or phenyl;
- R7 is hydrogen or C1-6alkyl;
- R7a is aryl optionally substituted with 1, 2, 3, or 4 R7h;
- heterocyclic optionally substituted with 1, 2, 3, or 4 R7b;
- or biphenyl optionally substituted with 1, 2, 3, or 4 R7b;
- and
- each R7b, when present, is independently halo, C1-6alkyl, halo-C1-6alkyl, aryl-C1-6alkyl, hydroxy, C1-6alkoxy, halo-C1-6alkoxy, aryloxy, nitro, C1-6alkylthio, halo-C1-6alkylthio, C1-6alkylsulfinyl, halo-C1-6alkylsulfinyl, C1-6alkylsulfonyl, halo-C1-6alkylsulfonyl, amino, C1-6alkylamino, di-C1-6alkylamino, —C(O)(heterocycloalkyl), phenyl, or cyano;
- where the aryl in aryloxy and aryl-C1-6alkyl are optionally substituted with 1, 2, or 3 groups independently selected from C1-6alkyl, halo, and halo-C1-6alkyl;
- or
- a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, mixture of stereoisomers, tautomer, or combinations thereof.
37 more elements
A compound of Formula (X)
- or a salt thereof,
- wherein
- PG1 is a nitrogen-protecting group;
- PG2 is a nitrogen-protecting group;
- X2 is halo, CN, or N3;
- R2 is —NR7C(O)R7a;
- R7 is hydrogen or C1-6alkyl;
- R7a is aryl optionally substituted with 1, 2, 3, or 4 R7b;
- heterocyclic optionally substituted with 1, 2, 3, or 4 R7b;
- or biphenyl optionally substituted with 1, 2, 3, or 4 R7b;
- and
- each R7b, when present, is independently halo, C1-6alkyl, halo-C1-6alkyl, aryl-C1-6alkyl, hydroxy, C1-6alkoxy, halo-C1-6alkoxy, aryloxy, nitro, C1-6alkylthio, halo-C1-6alkylthio, C1-6alkylsulfinyl, halo-C1-6alkylsulfinyl, C1-6alkylsulfonyl, halo-C1-6alkylsulfonyl, amino, C1-6alkylamino, di-C1-6alkylamino, —C(O)(heterocycloalkyl), phenyl, or cyano;
- where the aryl in aryloxy and aryl-C1-6alkyl are optionally substituted with 1, 2, or 3 groups independently selected from C1-6alkyl, halo, and halo-C1-6alkyl.
10 more elements
A method of preparing a compound of Formula (I) comprising
- a) in a single step, deprotecting and reducing a compound of Formula (X-1)
- to obtain a compound of Formula (X-2):
- or a salt thereof;
- b) coupling the compound of Formula (X-2) with a compound of Formula X4-LG to obtain a compound of Formula I;
- wherein
- PG1 is a nitrogen-protecting group;
- PG2 is a nitrogen-protecting group;
- X4 is —C(═O)R4a, —S(O)2R5a, —C(O)NR6aR6b, or —C(O)OR5a;
- LG is a leaving group selected from the group consisting of halo,
- where represents the point of attachment of LG to X4;
- R2 is —NR7C(O)R7a;
- R4a is hydrogen;
- C1-6alkyl;
- halo-C1-6alkyl;
- amino-C1-6alkyl;
- C1-6alkylaminoC1-6alkyl;
- di-C1-6alkylaminoC1-6alkyl;
- C1-6alkoxyC1-6alkyl;
- cycloalkyl;
- cycloalkylalkyl;
- aryl optionally substituted with 1, 2, 3, or 4 R4b groups;
- aralkyl where the aryl portion is optionally substituted with 1, 2, 3, or 4 R4b groups;
- heterocycloalkyl optionally substituted with 1, 2, 3, or 4 R4b groups;
- heteroaryl optionally substituted with 1, 2, 3, or 4 R4b groups;
- heteroaralkyl where the heteroaryl portion is optionally substituted with 1, 2, 3, or 4 R4b groups;
- heterocyclic optionally substituted with 1, 2, 3, or 4 R4b groups;
- or heterocyclicalkyl optionally substituted with 1, 2, 3, or 4 R4b groups;
- each R4b, when present, is independently C1-6alkyl, hydroxy, halo, halo-C1-6alkyl, hydroxy-C1-6alkyl, C1-6alkoxy, cyano, phenyl, or —O—(C1-6alkylene)-OZ, wherein Z is hydrogen or
- wherein Y is hydrogen or Boc group, and represents the point of attachment;
- R5a is heterocycloalkyl, amino, C1-6alkylamino, or di-C1-6alkylamino;
- R6a is hydrogen, or C1-6alkyl;
- R6b is hydrogen, C1-6alkyl, C1-6alkoxy or cycloalkyl;
- R8a is hydrogen, C1-6alkyl, cycloalkyl or phenyl;
- R7 is hydrogen or C1-6alkyl;
- R7a is aryl optionally substituted with 1, 2, 3, or 4 R7b;
- heterocyclic optionally substituted with 1, 2, 3, or 4 R7b;
- or biphenyl optionally substituted with 1, 2, 3, or 4 R7b;
- and
- each R7b, when present, is independently halo, C1-6alkyl, halo-C1-6alkyl, aryl-C1-6alkyl, hydroxy, C1-6alkoxy, halo-C1-6alkoxy, aryloxy, nitro, C1-6alkylthio, halo-C1-6alkylthio, C1-6alkylsulfinyl, halo-C1-6alkylsulfinyl, C1-6alkylsulfonyl, halo-C1-6alkylsulfonyl, amino, C1-6alkylamino, di-C1-6alkylamino, —C(O)(heterocycloalkyl), phenyl, or cyano;
- where the aryl in aryloxy and aryl-C1-6alkyl are optionally substituted with 1, 2, or 3 groups independently selected from C1-6alkyl, halo, and halo-C1-6alkyl;
- to yield a compound of Formula I;
- and
- c) optionally isolating the compound of Formula I.
40 more elements
Dependencies are inferred from the claim text.